RPRX- Royalty Pharma Plc

Name: Royalty Pharma Plc Insider Trading Data
Creator: U.S. Securities and Exchange Commission
License: https://www.sec.gov/privacy#accessibility

Royalty Pharma Plc (RPRX) has 15 insiders with recent SEC Form 4 filings, including 0 buys and 17 sells. RPRX is classified in the Biotechnology industry within the Health Care sector.

Insider Ownership

Role	Insider	Shares	Value	30d
CEO	Legorreta Pablo G.	941.0K	$47.79M	-
VP	Hite Christopher	658.5K	$33.45M	-
Dir	Norden Gregory	194.8K	$9.90M	-
Dir	Desouza Errol B	81.4K	$4.13M	-
?	Bassler Bonnie L	73.1K	$3.71M	-

Activity

Buys and sells only

Transactions

10 filings · page 4

Date	Insider	Role	Type	Shares	Price	Value	Chg%	3M	12M
Mar 30, 2023	Riggs Rory B67	Director	Sell	139,950	$36.31	$5,081,110.88	-4.4%	-18.5%	-16.3%
Mar 29, 2023	Lloyd George W.71	EVP, Investments &CLO	Sell	112,779	$37.06	$4,179,295.48	-20.5%	-18.4%	-16.9%
Feb 23, 2023	Lloyd George W.71	EVP, Investments &CLO	Sell	25,000	$37.27	$931,657.50	-7.1%	-13.2%	-16.5%
Feb 22, 2023	Urist Marshall73	EVP, Research &Investments	Sell	23,333	$37.30	$870,239.23	-33.3%	-11.0%	-16.5%
Dec 9, 2022	Riggs Rory B67	Director	Sell	19,990	$42.07	$840,939.32	-12.8%	-19.7%	-31.6%
Dec 5, 2022	Giuliani Mario Germano84	Director, 10% Owner	Sell	84,302	$43.15	$3,637,462.70	-1.1%	-18.3%	-33.9%
Dec 2, 2022	Giuliani Mario Germano84	Director, 10% Owner	Sell	362,766	$44.04	$15,974,737.48	-1.2%	-19.5%	-37.6%
Nov 22, 2022	Lloyd George W.71	EVP, Investments &CLO	Sell	40,000	$43.14	$1,725,566.58	-3.9%	-14.0%	-37.3%
Nov 17, 2022	Riggs Rory B67	Director	Sell	120,000	$42.33	$5,079,924.00	-43.4%	-11.0%	-37.2%
Nov 10, 2022	Lloyd George W.71	EVP, Investments &CLO	Sell	50,000	$43.85	$2,192,612.50	-8.8%	-13.1%	-37.8%

← PrevPage 4Next →

Insider	Role	Shares	Value	Buys	Sells

Date	Ticker	Insider	Role	Type	Shares	Price	Value	Chg%	SEC